[ad_1]
The Medicines and Healthcare Products Regulatory Agency (MHRA), the UK’s medical regulator, is likely to give a green signal to the coronavirus vaccine jointly developed by BioNTech SE and Pfizer Inc from December 7, the Financial reported. Times (FT), citing unnamed sources.
Vaccine deliveries would begin within hours of authorization, the sources added.
The government asked the regulator on Friday to evaluate AstraZeneca Plc’s vaccine for a possible launch.
Among other vaccine updates, the British government has secured two million doses of Moderna Inc’s COVID-19 candidate vaccine, which will be available in Europe from spring, according to a statement issued by No. 10.
Covid vaccines have shown greater than 90% efficacy in preventing infections in their respective late stage trials.
Market implications
Positive developments around the coronavirus vaccine are likely to bode well for risk sentiment and the pound, as the EU and UK push for a Brexit trade deal next week.
The European Commission has begun to “lean” on EU negotiator Michel Barnier to reach an agreement with the United Kingdom, raising hopes that a deal can be reached, The Times reported Saturday, citing a UK source. United Kingdom.
Both sides are struggling to find common ground as the three main issues in dispute continue to persist: fisheries, state aid, and how to resolve any future disputes.
